Abstract:Cluster of differentiation (CD) 80 is mainly expressed in immune cells but can also be found in several types of cancer cells. This molecule may either activate or inhibit immune reactions. Here, we determined the immunosuppressive role of CD80 in the tumor microenvironment by CRISPR/Cas9-mediated deactivation of the corresponding gene in the mouse oncogenic TC-1 cell line. The tumor cells with deactivated CD80 (TC-1/dCD80-1) were more immunogenic than parental cells and induced tumors that gained sensitivity to cytotoxic T-lymphocyte antigen 4 (CTLA-4) blockade, as compared with the TC-1 cells. In vivo depletion experiments showed that the deactivation of CD80 switched the pro-tumorigenic effect of macrophages observed in TC-1-induced tumors into an anti-tumorigenic effect in TC-1/dCD80-1 tumors and induced the pro-tumorigenic activity of CD4+ cells. Moreover, the frequency of lymphoid and myeloid cells and the CTLA-4 expression by T helper (Th)17 cells were increased in TC-1/dCD80-1- compared with that in the TC-1-induced tumors. CTLA-4 blockade downregulated the frequencies of most immune cell types and upregulated the frequency of M2 macrophages in the TC-1 tumors, while it increased the frequency of lymphoid cells in TC-1/dCD80-1-induced tumors. Furthermore, the anti-CTLA-4 therapy enhanced the frequency of CD8+ T cells as well as CD4+ T cells, especially for a Th1 subset. Regulatory T cells (Treg) formed the most abundant CD4+ T cell subset in untreated tumors. The anti-CTLA-4 treatment downregulated the frequency of Treg cells with limited immunosuppressive potential in the TC-1 tumors, whereas it enriched this type of Treg cells and decreased the Treg cells with high immunosuppressive potential in TC-1/dCD80-1-induced tumors. The immunosuppressive role of tumor-cell-expressed CD80 should be considered in research into biomarkers for the prediction of cancer patients’ sensitivity to immune checkpoint inhibitors and for the development of a tumor-cell-specific CD80 blockade.

CD8 is down(regulated) for tolerance

Regulation Of Cd8(+) Regulatory T Cells: Interruption Of The Nkg2a-Qa-1 Interaction Allows Robust Suppressive Activity And Resolution Of Autoimmune Disease

Generation and Regulation of CD8(+) Regulatory T Cells.

Inhibition of follicular T-helper cells by CD8 + regulatory T cells is essential for self tolerance

Cd11c(High)Cd8(+) Regulatory T Cell Feedback Inhibits Cd4 T Cell Immune Response Via Fas Ligand-Fas Pathway

CD8+NKT-like Cells Regulate the Immune Response by Killing Antigen-Bearing DCs

A CD8 T cell-intrinsic role for the calcineurin-NFAT pathway for tolerance induction in vivo

CD8+ T cell tolerance: It doesn't translate

Caspase-8 has dual roles in regulatory T cell homeostasis balancing immunity to infection and collateral inflammatory damage

The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

Qa-1 Restriction of CD8+ Suppressor T Cells

CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function

Regulatory T cells control type 1-driven immunopathology restraining GM-CSF-producing helper T cells

CD8+ T Activation Attenuates CD4+ T Proliferation Through Dendritic Cells Modification

T-cell tolerance or function is determined by combinatorial costimulatory signals.

Tuning of antigen sensitivity by T cell receptor-dependent negative feedback controls T cell effector function in inflamed tissues

Human CD8+HLA-DR+ Regulatory T Cells, Similarly to Classical CD4+Foxp3+ Cells, Suppress Immune Responses via PD-1/PD-L1 Axis

CD80 Expression on Tumor Cells Alters Tumor Microenvironment and Efficacy of Cancer Immunotherapy by CTLA-4 Blockade

Peripheral Homeostasis of CD4~+CD25~+ Regulatory T Cells

Mechanisms Underlying CD4+ Treg Immune Regulation in the Adult: From Experiments to Models

CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas